+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035 - Product Thumbnail Image

Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035

  • Report
  • March 2025
  • 245 Pages
  • Global
From
Global CBD Regulatory Database - Product Thumbnail Image

Global CBD Regulatory Database

  • Database
  • October 2024
  • Global
Global Medical and Recreational Cannabis Database - Product Thumbnail Image

Global Medical and Recreational Cannabis Database

  • Database
  • September 2024
  • Global
From
From
CD137 Antibodies Clinical Trials & Market Opportunity Insight - Product Thumbnail Image

CD137 Antibodies Clinical Trials & Market Opportunity Insight

  • Report
  • September 2024
  • 210 Pages
  • Global
From
From
From
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets - Product Thumbnail Image

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

  • Report
  • December 2024
  • 125 Pages
  • Global
From
From
From
NASH Market Outlook 2037 - Product Thumbnail Image

NASH Market Outlook 2037

  • Report
  • November 2024
  • 223 Pages
  • Global
From
From
Conventional and Alternative Pain Treatment Market - Product Thumbnail Image

Conventional and Alternative Pain Treatment Market

  • Report
  • November 2024
  • 173 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more